CGEN vs DBVT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CGEN

66.1
AI Score
VS
CGEN Wins

DBVT

61.3
AI Score

Investment Advisor Scores

CGEN

66score
Recommendation
STRONG BUY

DBVT

61score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CGEN DBVT Winner
Forward P/E 12.3609 0 Tie
PEG Ratio 1.2874 0 Tie
Revenue Growth 107.0% -53.3% CGEN
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 66.1/100 61.3/100 CGEN
Profit Margin 47.6% 0.0% CGEN
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD CGEN

Relative Price Performance (Last 90 Days)

CGEN 1M: -14.9% · 3M: -9.4% DBVT 1M: -23.8% · 3M: -30.6%

Current Technical Phase

CGEN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 44

RSI (14): 43.7 · Price: $2.12

DBVT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.3%), weak momentum, RSI 37

RSI (14): 37.5 · Price: $9.62

Fundamentals Snapshot

Metric CGEN DBVT
Market Cap — —
Forward P/E -5.8 -22.2
Trailing P/E 5.6 —
Revenue (TTM) — —
Revenue Growth 1.1% -0.5%
Gross Margin 0.9% 1.0%
Operating Margin -3.4% -72.3%
EPS 0.38 -3.50
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.